1 / 84

Catheter Associated Urinary Tract Infections (CAUTI): Monitoring and Prevention.

George Allen PhD, CIC, CNOR. Catheter Associated Urinary Tract Infections (CAUTI): Monitoring and Prevention. Disclosures. No Disclosures. Objectives. Identify mandates, clinical & regulatory for monitoring and preventing CAUTI Review the surveillance definitions and criteria for CAUTI

erasmus-hawkins
Download Presentation

Catheter Associated Urinary Tract Infections (CAUTI): Monitoring and Prevention.

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. George Allen PhD, CIC, CNOR Catheter Associated Urinary Tract Infections (CAUTI): Monitoring and Prevention.

  2. Disclosures • No Disclosures

  3. Objectives • Identify mandates, clinical & regulatory for monitoring and preventing CAUTI • Review the surveillance definitions and criteria for CAUTI • Discuss strategies institutions can utilize to reduce the risk for the development of CAUTI

  4. Issues Associated with Urinary Catheters – Clinical Mandate • Discomfort to the patient • Limit mobility • Prolonged hospital stay • Increased cost and mortality

  5. The Burden of HAI • Each year 1.7- 2 million Americans (5-10% of hospitalized patients) acquire at least one infection while hospitalized • 90-100 thousand die of those infections • One third of these are believed preventable • Conservatively HAI cost $33 billion each year

  6. The Burden of CAUTI • Urinary tract – most common site of healthcare associated infections; most are associated with urinary catheterization • 15 - 25% of inpatients are catheterized • 80% of hospital associated UTIs caused by a urinary catheter

  7. The Burden of CAUTI • CAUTI cost $500 – $1000 - $2,800 if bacteremia • Most CAUTIs are asymptomatic bacteriuria, 1-5% lead to secondary bacteremia • 5% of all deaths from HAI are urinary catheter associated.

  8. The Burden of HAI • CAUTI are the most common HAI accounting for about 30% • Each year more than 13,000 deaths are associated with UTI Klevens RM, Edwards JR, et al. Estimating health care-associated infections and deaths in U. S hospitals, 2002. Public Health Reports 2007: 122:160-166.

  9. The Burden of HAI • The good news is that many CAUTIs may be prevented with recommended infection control measures. • Up to 380,000 infections and 9000 deaths related to CAUTI per year could be prevented http://www.cdc.gov/ncidod/dhqp/hai.html Umscheid et al. Infec Control & Hospital Epidemiology 2011; Scott, 2009

  10. The Burden of CAUTI • Proper management and use of catheters could prevent infections • Study in Lansing, MI: Less than half of urinary catheters in teaching hospital were indicated. Am J Infect Control. 2004 Jun;32(4):196-9. Inappropriate use of urinary catheters in elderly patients at a midwestern community teaching hospital.Gokula RR, Hickner JA, Smith MA. • Urinary catheters are uncomfortable, limit mobility

  11. The Burden of CAUTI • Virtually all healthcare associated urinary tract infection are caused by instrumentation of the urinary tract • CAUTI can lead to complications

  12. Complications of CAUTI • Cystitis • Pyelonephritis • Gram-negative bacteremia • Prostatitis • Epididymitis • Orchitis in males

  13. Complications of CAUTI • Endocarditis • Vertebral osteomyelitis • Septic arthritis • Endophthalmitis • Meningitis

  14. Regulatory Mandate • The Joint Commission NSPG 07.06.01 • CMS Value Based Purchasing • CMS Inpatient Quality Reporting Program • Goals • To eliminate and sustain reductions in CAUTI

  15. Regulatory Mandate • Mandatory Reporting through NHSN • Denial of CMS dollar reimbursement Core Measures • CAUTI must be included in monthly NHSN • NY Partnership for Patients • To reduce unnecessary catheter utilization • To eliminate preventable catheter-associated urinary tract infections

  16. Centers for Medicare & Medicaid (CMS) • As of Oct. 2008 CMS will no longer reimburse hospitals for eight “reasonably preventable” conditions. • Included are CAUTI and hospital acquired pressure ulcers. • Reimbursement to the hospital for care of these patients will be decreased.

  17. CMS Requirement – Pay for ReportingCMS 2012 IPPS Final Rule Report by the following facility/institution: • Acute Care Hospitals: Adult and Pediatric ICUs • January 2011 • Long Term Care Hospitals: All inpatient location • October 2012 • Inpatient Rehabilitation Facilities: All inpatient locations • October 2012

  18. Monthly Reporting - NHSN Report CAUTI indentified by surveillance Indicate NO CAUTI detected for specific location Report total device days for specific location Report total patient days in specific location

  19. The Joint Commission • NPSG.07.06.01 Implement evidence based practices to prevent CAUTI (2012 = Planning year; by January 2013 = full implementation) http://www.jointcommission.org/assets/1/6/NPSGs_CAUTI-VAP_HAP_20101119.pdf

  20. The Joint Commission

  21. The Joint Commission

  22. GUIDELINE FOR PREVENTION OF CATHETER-ASSOCIATED URINARY TRACT INFECTIONS 2009 Carolyn V. Gould, MD, MSCR 1; Craig A. Umscheid, MD, MSCE 2; Rajender K. Agarwal, MD, MPH 2; Gretchen Kuntz, MSW, MSLIS 2; David A. Pegues, MD 3 and the Healthcare Infection Control Practices Advisory Committee (HICPAC) 4

  23. Modified HICPAC Categorization Scheme for Recommendations

  24. Need for Urinary Catheterization • 1A.1. Use urinary catheters in operative patients only as necessary, rather than routinely. (Category IB) • 1A.2. Avoid use of urinary catheters in patients and nursing home residents for management of incontinence. (Category IB)

  25. Need for Urinary Catheterization • 1A.2.a. Further research is needed on periodic (e.g., nighttime) use of external catheters in incontinent patients or residents and the use of catheters to prevent skin breakdown. (No recommendation/unresolved issue) • 1A.3. Further research is needed on the benefit of using a urethral stent as an alternative to an indwelling catheter in selected patients with bladder outlet obstruction. (No recommendation/unresolved issue)

  26. Need for Urinary Catheterization • 1A.4. Consider alternatives to chronic indwelling catheters, such as intermittent catheterization, in spinal cord injury patients. (Category II) • 1A.5. Consider intermittent catheterization in children with myelomeningocele and neurogenic bladder to reduce the risk of urinary tract deterioration. (Category II)

  27. Risk Factors for CAUTI • 1B.2. Insert catheters only for appropriate indications, and leave in place only as long as needed. (Category IB) • 1B.3. Minimize urinary catheter use and duration of use in all patients, particularly those at higher risk for CAUTI such as women, the elderly, and patients with impaired immunity. (Category IB)

  28. Risk Factors for CAUTI • 1B.4. Ensure that only properly trained persons (e.g., hospital personnel, family members, or patients themselves) who know the correct technique of aseptic catheter insertion and maintenance are given this responsibility. (Category IB) • 1B.5. Maintain unobstructed urine flow. (Category IB)

  29. Population at Highest Risk of Mortality • 1C.1. Minimize urinary catheter use and duration in all patients, particularly those who may be at higher risk for mortality due to catheterization, such as the elderly and patients with severe illness. (Category IB)

  30. Risks & Benefits Different Approaches • 2A.1. Consider using external catheters as an alternative to indwelling urethral catheters in cooperative male patients without urinary retention or bladder outlet obstruction. (Category II) • 2A.2. Intermittent catheterization is preferable to indwelling urethral or suprapubic catheters in patients with bladder emptying dysfunction. (Category II)

  31. Risks & Benefits Different Approaches • 2A.3. If intermittent catheterization is used, perform it at regular intervals to prevent bladder over-distension. (Category IB) • 2A.4. For operative patients who have an indication for an indwelling catheter, remove the catheter as soon as possible postoperatively, preferably within 24 hours, unless there are appropriate indications for continued use. (Category IB)

  32. Risks & Benefits Different Approaches • 2A.5. Further research is needed on the risks and benefits of suprapubic catheters as an alternative to indwelling urethral catheters in selected patients requiring short- or long-term catheterization, particularly with respect to complications related to catheter insertion or the catheter site. (No recommendation/unresolved issue)

  33. Risks & Benefits Different Approaches • 2A.6. In the non-acute care setting, clean (i.e., non-sterile) technique for intermittent catheterization is an acceptable and more practical alternative to sterile technique for patients requiring chronic intermittent catheterization. (Category IA)

  34. Risk & Benefits Collecting Systems • 2B.1. If the CAUTI rate is not decreasing after implementing a comprehensive strategy to reduce rates of CAUTI, consider using antimicrobial/antiseptic-impregnated catheters. The comprehensive strategy should include, at a minimum, the high priority recommendations for urinary catheter use, aseptic insertion, and maintenance (Category IB)

  35. Risk & Benefits Collecting Systems • 2B.1.a. Further research is needed on the effect of antimicrobial/antiseptic-impregnated catheters in reducing the risk of symptomatic UTI, their inclusion among the primary interventions, and the patient populations most likely to benefit from these catheters. (No recommendation/unresolved issue)

  36. Risk & Benefits Collecting Systems • 2B.2. Hydrophilic catheters might be preferable to standard catheters for patients requiring intermittent catheterization. (Category II) • 2B.3. Following aseptic insertion of the urinary catheter, maintain a closed drainage system. (Category IB) • 2B.4. Complex urinary drainage systems (utilizing mechanisms for reducing bacterial entry such as antiseptic-release cartridges in the drain port) are not necessary for routine use. (Category II)

  37. Risk & Benefits Collecting Systems • 2B.5. Urinary catheter systems with pre-connected, sealed catheter-tubing junctions are suggested for use. (Category II) • 2B.6. Further research is needed to clarify the benefit of catheter valves in reducing the risk of CAUTI and other urinary complications. (No recommendation/unresolved issue)

  38. Risk & Benefits Catheter Management • 2C.1. Unless clinical indications exist (e.g., in patients with bacteriuria upon catheter removal post urologic surgery), do not use systemic antimicrobials routinely as prophylaxis for UTI in patients requiring either short or long-term catheterization. (Category IB) • 2C.2.a. Further research is needed on the use of urinary antiseptics (e.g., methanamine) to prevent UTI in patients requiring short-term catheterization. (No recommendation/unresolved issue)

  39. Risk & Benefits Catheter Management • 2C.2.b. Further research is needed on the use of methanamine to prevent encrustation in patients requiring chronic indwelling catheters who are at high risk for obstruction. (No recommendation/unresolved issue) • 2C.3.a. Unless obstruction is anticipated (e.g., as might occur with bleeding after prostatic or bladder surgery), bladder irrigation is not recommended. (Category II) • 2C.3.b. Routine irrigation of the bladder with antimicrobials is not recommended. (Category II)

  40. Risk & Benefits Catheter Management • 2C.4. Routine instillation of antiseptic or antimicrobial solutions into urinary drainage bags is not recommended. (Category II) • 2C.5.a. Do not clean the periurethral area with antiseptics to prevent CAUTI while the catheter is in place. Routine hygiene (e.g., cleansing of the meatal surface during daily bathing)

  41. Risk & Benefits Catheter Management • 2C.5.b. Further research is needed on the use of antiseptic solutions vs. sterile water or saline for periurethral cleaning prior to catheter insertion. (No recommendation/unresolved issue) • 2C.6. Changing indwelling catheters or drainage bags at routine, fixed intervals is not recommended. Rather, catheters and drainage bags should be changed based on clinical indications such as infection, obstruction, or when the closed system is compromised. (Category II)

  42. Risk & Benefits Catheter Management • 2C.7.a. Use a sterile, single-use packet of lubricant jelly for catheter insertion.(Category IB) • 2C.7.b. Routine use of antiseptic lubricants is not necessary. (Category II) • 2C.8. Further research is needed on the use of bacterial interference to prevent UTI in patients requiring chronic urinary catheterization. (No recommendation/unresolved issue)

  43. Risk & Benefits Catheter Management • 2C.9. Further research is needed on optimal cleaning and storage methods for catheters used for clean intermittent catheterization. (No recommendation/unresolved issue) • 2C.10.a. Clamping indwelling catheters prior to removal is not necessary. (Category II) • 2C.10.b. Insert catheters only for appropriate indications, and leave in place only as long as needed. (Category IB)

  44. Risk & Benefits Catheter Management • 2C.10.c. For operative patients who have an indication for an indwelling catheter, remove the catheter as soon as possible postoperatively, preferably within 24 hours, unless there are appropriate indications for continued use. (Category IB) • 2C.11.a. Consider using a portable ultrasound device to assess urine volume in patients undergoing intermittent catheterization to assess urine volume and reduce unnecessary catheter insertions. (Category II)

  45. Risk & Benefits Catheter Management • 2C.11.b. Further research is needed on the use of a portable ultrasound device to evaluate for obstruction in patients with indwelling catheters and low urine output. (No recommendation/unresolved issue)

  46. Risk & Benefits System Interventions • 2D.1.a. Ensure that healthcare personnel and others who take care of catheters are given periodic in-service training stressing the correct techniques and procedures for urinary catheter insertion, maintenance, and removal. (Category IB) • 2D.1.b. Implement quality improvement (QI) programs or strategies to enhance appropriate use of indwelling catheters and to reduce the risk of CAUTI based on a facility risk assessment. (Category IB)

  47. Risk & Benefits System Interventions • 2D.2. Routine screening of catheterized patients for asymptomatic bacteriuria is not recommended. (Category II) • 2D.3. Perform hand hygiene immediately before and after insertion or any manipulation of the catheter site or device. (Category IB)

  48. Risk & Benefits System Interventions • 2D.5. Maintain unobstructed urine flow. (Category IB) • 2D.6. Further research is needed on the benefit of spatial separation of patients with urinary catheters to prevent transmission of pathogens colonizing urinary drainage systems. (No recommendation/unresolved issue) • 2D.7. When performing surveillance for CAUTI, consider providing regular (e.g., quarterly) feedback of unit-specific CAUTI rates to nursing staff and other appropriate clinical care staff. (Category II)

  49. Indication for Urinary Catheter • Urinary Tract Obstruction and Neurogenic Bladder • Urologic Study/Surgery • Urine monitoring in critically ill patients • Assistance in pressure ulcer management for incontinent patients • Exception – Patient request to improve comfort

  50. NOT Indications for Urinary Catheter • Incontinence • Immobility • Patient/Staff Convenience • Obtaining Periodic Urine Specimens

More Related